Hemab Therapeutics, chaired by former Alnylam chief executive John Maraganore, has published its redacted IPO prospectus with ...
Heart attacks remain one of the leading causes of death around the world. They often happen when a blood clot blocks the flow ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results